EPO Patents = 2

Forward Citations = 0

Loading Chart...

12 inventors (with patents filed for the assignee):

Govindarajulu Babu (3 out of 22 patents)

Swaroop K Vakkalanka (3 out of 34 patents)

Srikant Viswanadha (3 out of 39 patents)

4. Prashant Kashinath Bhavar (2 out of 16 patents)

5. Swaroop Kumar Venkata Satya Vakkalanka (2 out of 2 patents)

6. Meyyappan Muthuppalaniappan (1 out of 32 patents)

7. Jayaraman Venkat Raman (1 out of 5 patents)

8. Sridhar Veeraraghavan (1 out of 1 patent)

9. Babu Govindarajulu (1 out of 1 patent)

10. Prashant K Bhavar (1 out of 1 patent)

11. Debnath Bhuniya (1 patent)

12. Gayatri Swaroop Merikapudi (13 patents)

5 patents: Sort by Forward Citations

1. 12428422 - Purine derivatives as SIK-3 inhibitors (2025-09-30),

2. 11858907 - Kinase modulators (2024-01-02),

3. 11478481 - Process for preparation of optically pure and optionally substituted 2-(1-hydroxy-alkyl)-chromen-4-one derivatives and their use in preparing pharmaceuticals (2022-10-25),

4. 11466006 - Dual selective PI3 delta and gamma kinase inhibitors (2022-10-11),

5. 11352359 - PI3K protein kinase inhibitors (2022-06-07),

Rhizen Pharmaceuticals AG is a biopharmaceutical company focused on the discovery and development of innovative small molecule therapeutics in the areas of oncology and inflammatory diseases. Through their cutting-edge research and development programs, Rhizen Pharmaceuticals is committed to delivering breakthrough treatments that improve the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

5 Patents

#59 in Basel

#1,658 in Switzerland

Basel, Switzerland

Rhizen Pharmaceuticals Ag